Sign in
4/A

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-016231

Director sold 360 shares at $218.29 ($78,584)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
De Witte Jan Director 2024-05-15 Sale 10b5-1 −360 $218.29 $78,584 7,519 D
Open-market sales · 360 sh · avg $218.29 · $78,584
Loading xslF345X05/form4a.xml…